OncBioMune Pharmaceuticals competitorsClear all

OncBioMune Pharmaceuticals's top competitors include Northwest Biotherapeutics, Merrimack Pharmaceuticals and CytomX Therapeutics.
OncBioMune Pharmaceuticals
OncBioMune Pharmaceuticals
OncBioMune specializes in innovative cancer research.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Founding Date
Founding Date
2005
Founding Date
1998
Founding Date
2000
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Baton Rouge, US HQ
Locations
Bethesda, US HQ
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
3
Employees
1721% increase
Employees
2763% decrease
Employees
15815% increase
Valuation ($)
Valuation ($)
320.2 k
Valuation ($)
1.2 b
Valuation ($)
101.2 m
Valuation ($)
307.4 m
Twitter followers
Twitter followers
2.4 k
Twitter followers
2.3 k
Twitter followers
1.1 k
Twitter followers
889
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
616184
Alexa Website Rank
411721
Alexa Website Rank
281860
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$2.4m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$57.5m (FY, 2019)
Net income
Net income
($9.4m) (FY, 2019)
Net income
($20.3m) (FY, 2019)
Net income
($17.3m) (FY, 2019)
Net income
($102.2m) (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 135.9m
Total funding raised
$ 79.4m
Total funding raised
$ 132.4m
For sources of this data, please see the company profile

View company profiles

Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company